Join our Free Newsletter and unlock 50% off AltIndexFree newsletter + 50% offJoin free
0
Subscribing Stocktwits Users.
Loading...

Mainz Biomed Stocktwits Subscriber Count

Mainz Biomed (MYNZ) has 0 subscribers on Stocktwits, roughly flat (+0.0%) over the past three months.

Unlike daily Stocktwits mentions, which spike around news and earnings, subscriber count reflects sustained, long-term interest from the retail investor community.

How MYNZ’s Stocktwits Community Feeds the AI Score

Stocktwits subscriber count is a direct read on the size of the retail investor community tracking MYNZ. It is not a stock price on its own, but sustained growth in subscribers can reflect building retail interest. AltIndex feeds Mainz Biomed’s Stocktwits community into the MYNZ AI Score as one of 25+ alternative data signals, weighed against sentiment, Reddit activity, and fundamentals.

For daily discussion volume, see MYNZ Stocktwits mentions. For other retail-community metrics, see Reddit subscribers and Reddit mentions.

Month over Month Stocktwits Subscribers

Feb 2026 17,439
Jan 2026 17,464
Dec 2025 17,363
Nov 2025 17,342
Get MYNZ alerts in real-time
The moment the stocktwits subscribers trend turns, sentiment flips, or insiders trade.
Try Stock Alerts Free

Mainz Biomed Stocktwits Subscribers: Frequently Asked Questions

Mainz Biomed (MYNZ) has 0 subscribers (0) on Stocktwits, based on AltIndex’s tracking of the stock’s Stocktwits page.

Mainz Biomed's Stocktwits subscriber base has been roughly flat (+0.0%) over the past three months. View the trend chart above for the full history.

Stocktwits subscriber count is a proxy for the size of the retail investor community tracking a stock. Unlike daily mentions, which spike around news, subscriber growth reflects sustained interest. No single data point predicts a stock on its own, which is why AltIndex combines MYNZ’s Stocktwits community with sentiment, Reddit activity, and 20+ other signals in its AI Score rather than reading any one signal in isolation.

Sign up and get more insights on Mainz Biomed.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.